Tudor Investment Corp’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.2K | Hold |
71,008
| – | – | ﹤0.01% | 1481 |
|
|
2025
Q1 | $104K | Buy |
+71,008
| New | +$104K | ﹤0.01% | 1442 |
|
|
2024
Q3 | – | Sell |
-71,340
| Closed | -$166K | – | 1529 |
|
|
2024
Q2 | $166K | Sell |
71,340
-412
| -0.6% | -$960 | ﹤0.01% | 1377 |
|
|
2024
Q1 | $321K | Buy |
+71,752
| New | +$321K | ﹤0.01% | 1208 |
|
|
2023
Q4 | – | Sell |
-73,998
| Closed | -$235K | – | 1446 |
|
|
2023
Q3 | $235K | Buy |
73,998
+63,135
| +581% | +$200K | ﹤0.01% | 1297 |
|
|
2023
Q2 | $54K | Buy |
+10,863
| New | +$54K | ﹤0.01% | 1456 |
|
|
2023
Q1 | – | Sell |
-77,228
| Closed | -$486K | – | 1525 |
|
|
2022
Q4 | $486K | Buy |
77,228
+60,175
| +353% | +$379K | 0.01% | 1126 |
|
|
2022
Q3 | $184K | Buy |
+17,053
| New | +$184K | ﹤0.01% | 1428 |
|
|
2022
Q2 | – | Sell |
-171,247
| Closed | -$1.56M | – | 1539 |
|
|
2022
Q1 | $1.56M | Buy |
171,247
+99,356
| +138% | +$905K | 0.04% | 645 |
|
|
2021
Q4 | $1.07M | Buy |
+71,891
| New | +$1.07M | 0.02% | 847 |
|
|
2021
Q3 | – | Sell |
-98,912
| Closed | -$2.58M | – | 1510 |
|
|
2021
Q2 | $2.58M | Buy |
+98,912
| New | +$2.58M | 0.05% | 433 |
|
|
2021
Q1 | – | Sell |
-12,120
| Closed | -$306K | – | 1499 |
|
|
2020
Q4 | $306K | Buy |
12,120
+1,197
| +11% | +$30.2K | 0.01% | 1099 |
|
|
2020
Q3 | $412K | Sell |
10,923
-39,476
| -78% | -$1.49M | 0.02% | 884 |
|
|
2020
Q2 | $2.16M | Buy |
+50,399
| New | +$2.16M | 0.11% | 224 |
|